The FLOW trial of semaglutide, the DANCAVAS CV screening trial, non-invasive tests for chest pain, and conflicts of interest on social media are the topics John Mandrola, MD, discusses this week.


This podcast is intended for healthcare professionals only.


To read a partial transcript or to comment, visit:


[ Ссылка ]


I. Semaglutide for CKD


Semaglutide Significantly Improves Chronic Kidney Disease


[ Ссылка ]


• FLOW Trial


II. CV Screening


Judicious CVD Screening May Work in Men: DANCAVAS


[ Ссылка ]


• DANCAVAS 6-Year Outcomes [ Ссылка ]

• DANCAVAS Main Trial NEJM [ Ссылка ]


III. Non-invasive Cardiac Testing in Chest Pain


• Circulation Outcomes Paper [ Ссылка ]

• Scot Heart [ Ссылка ]


IV. COI and Social Media


• JAMA letter [ Ссылка ]


You may also like:


The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. [ Ссылка ]


Questions or feedback, please contact news@medscape.net

свернуть